TWO SIGMA SECURITIES, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
TWO SIGMA SECURITIES, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,780,778
+139.6%
27,300
+137.4%
0.03%
+70.6%
Q2 2023$1,160,465
-39.6%
11,500
-45.7%
0.02%
-70.7%
Q4 2022$1,922,629
+83.3%
21,193
+53.5%
0.06%
+81.2%
Q3 2022$1,049,000
-39.3%
13,803
-32.5%
0.03%
-47.5%
Q2 2022$1,728,000
+198.4%
20,440
+209.7%
0.06%
+205.0%
Q1 2022$579,000
+20.6%
6,600
+20.2%
0.02%
-4.8%
Q4 2021$480,000
-52.0%
5,489
-48.2%
0.02%
-12.5%
Q4 2020$1,001,000
-22.2%
10,600
-28.4%
0.02%
-7.7%
Q3 2020$1,287,000
+73.5%
14,800
+74.1%
0.03%
+52.9%
Q2 2020$742,000
+83.7%
8,500
+73.5%
0.02%
+88.9%
Q1 2020$404,000
-95.1%
4,900
-94.4%
0.01%
-83.9%
Q4 2019$8,266,000
+877.1%
87,300
+797.0%
0.06%
+600.0%
Q3 2019$846,000
-87.9%
9,732
-87.3%
0.01%
-88.9%
Q2 2019$6,976,000
+112.9%
76,400
+124.1%
0.07%
+148.3%
Q1 2019$3,277,000
-27.0%
34,091
-34.8%
0.03%
-47.3%
Q4 2018$4,486,000
-63.3%
52,268
-63.1%
0.06%
-31.2%
Q3 2018$12,215,000
-13.9%
141,770
-24.6%
0.08%
+12.7%
Q2 2018$14,195,000
-55.3%
187,911
-52.2%
0.07%
-60.1%
Q1 2018$31,774,000
+3646.9%
393,004
+3791.1%
0.18%
+673.9%
Q4 2017$848,000
+216.4%
10,100
+214.2%
0.02%
-54.9%
Q2 2017$268,000
-3.6%
3,215
-14.0%
0.05%
-5.6%
Q1 2017$278,0003,7400.05%
Other shareholders
NOVARTIS A G shareholders Q2 2019
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders